Sherwin-Williams (NYSE:SHW) Given New $383.00 Price Target at Royal Bank Of Canada

Key Points

• Royal Bank of Canada lowered Sherwin-Williams’ price target to $383 from $392 while maintaining an “outperform” rating, implying 16.25% upside from the prior close.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and average price target of $377.29, supported by 15 Buy and 12 Hold ratings.
• Sherwin-Williams’ quarterly revenue rose 7.9% to $6.86 billion and exceeded estimates, but EPS of $3.63 missed consensus by $0.06 amid cost and margin pressures.

Sherwin-Williams (NYSE:SHW - Get Free Report) had its target price reduced by Royal Bank Of Canada from $392.00 to $383.00 in a research note issued on Thursday, Benzinga reports. The firm presently has an "outperform" rating on the specialty chemicals company's stock. Royal Bank Of Canada's price target would indicate a potential upside of 16.25% from the company's previous close.

Several other equities analysts have also weighed in on SHW. DA Davidson set a $390.00 price objective on Sherwin-Williams and gave the company a "buy" rating in a report on Wednesday. UBS Group reaffirmed a "neutral" rating and set a $370.00 price target (up from $363.00) on shares of Sherwin-Williams in a research report on Wednesday. BMO Capital Markets restated an "outperform" rating on shares of Sherwin-Williams in a research report on Monday, September 28th. Berenberg Bank increased their target price on shares of Sherwin-Williams from $380.00 to $400.00 and gave the company a "buy" rating in a report on Wednesday, July 29th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Sherwin-Williams from $380.00 to $375.00 and set an "overweight" rating on the stock in a research report on Wednesday. Fifteen research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $377.29.

Sherwin-Williams Stock Performance

Sherwin-Williams stock traded up $8.66 during trading hours on Thursday, hitting $329.46. The company had a trading volume of 2,370,587 shares, compared to its average volume of 1,939,188. Sherwin-Williams has a one year low of $289.86 and a one year high of $377.77. The firm has a 50-day moving average of $330.16 and a 200 day moving average of $333.38. The company has a debt-to-equity ratio of 2.16, a current ratio of 0.73 and a quick ratio of 0.46. The firm has a market cap of $79.98 billion, a PE ratio of 30.36, a PEG ratio of 2.63 and a beta of 1.08.

Sherwin-Williams (NYSE:SHW - Get Free Report) last posted its earnings results on Tuesday, October 27th. The specialty chemicals company reported $3.63 EPS for the quarter, missing the consensus estimate of $3.69 by ($0.06). The firm had revenue of $6.86 billion during the quarter, compared to the consensus estimate of $6.78 billion. Sherwin-Williams had a net margin of 11.01% and a return on equity of 67.97%. Sherwin-Williams's revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $3.59 earnings per share. On average, sell-side analysts expect that Sherwin-Williams will post 12.07 earnings per share for the current year.

Insider Activity

In other Sherwin-Williams news, insider Justin T. Binns sold 13,500 shares of the business's stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $352.70, for a total value of $4,761,450.00. Following the completion of the transaction, the insider owned 21,937 shares of the company's stock, valued at approximately $7,737,179.90. The trade was a 38.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Karl Jorgenrud sold 7,886 shares of the company's stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $368.30, for a total transaction of $2,904,413.80. Following the transaction, the insider owned 11,944 shares in the company, valued at $4,398,975.20. This represents a 39.77% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.23% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Sherwin-Williams

A number of hedge funds have recently made changes to their positions in SHW. BlackRock Inc. purchased a new stake in shares of Sherwin-Williams during the second quarter valued at about $6,100,083,000. Wellington Management Group LLP grew its position in shares of Sherwin-Williams by 133.7% in the 2nd quarter. Wellington Management Group LLP now owns 2,784,679 shares of the specialty chemicals company's stock worth $958,821,000 after buying an additional 1,593,009 shares during the last quarter. Amundi raised its stake in shares of Sherwin-Williams by 20.6% during the 1st quarter. Amundi now owns 2,200,895 shares of the specialty chemicals company's stock worth $705,497,000 after acquiring an additional 376,505 shares in the last quarter. Bank of New York Mellon Corp bought a new position in shares of Sherwin-Williams during the 2nd quarter worth approximately $547,097,000. Finally, Dimensional Fund Advisors LP raised its stake in shares of Sherwin-Williams by 2.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,417,166 shares of the specialty chemicals company's stock worth $454,226,000 after acquiring an additional 39,853 shares in the last quarter. 77.67% of the stock is currently owned by hedge funds and other institutional investors.

Sherwin-Williams News Roundup

Here are the key news stories impacting Sherwin-Williams this week:

• Positive Sentiment: Management narrowed its FY26 adjusted EPS outlook range, potentially reducing uncertainty around the company’s earnings trajectory. The update followed the third-quarter report and appears to have provided some reassurance to investors. Sherwin-Williams Narrows FY26 Adjusted EPS Outlook Range
• Positive Sentiment: Third-quarter revenue rose 7.9% year over year to $6.86 billion, exceeding analysts’ expectations of $6.78 billion. Management also expects approximately $75 million in structural cost savings in 2027, which could support future margins and earnings growth. Sherwin-Williams Q3 2026 Earnings and Sales Growth
• Positive Sentiment: Sherwin-Williams continued its long record of shareholder returns, extending its dividend increase streak to 48 years. JPMorgan maintained an overweight rating, while UBS raised its price target to $370 and retained a neutral rating. UBS Sherwin-Williams Price Target Update
• Neutral Sentiment: Analyst target-price changes were mixed: JPMorgan reduced its target to $375 from $380, and DA Davidson cut its target to $390 from $400, while both firms’ targets remain above the current trading level. JPMorgan Sherwin-Williams Price Target Update
• Negative Sentiment: Adjusted third-quarter EPS was $3.63, below the $3.69 consensus estimate, as higher costs and margin pressure offset the revenue beat. The earnings disappointment caused the stock to gap lower and trade below its 200-day moving average, signaling continued near-term technical weakness. Sherwin-Williams Stock Breaks Below 200-Day Moving Average

Sherwin-Williams Company Profile

The Sherwin-Williams Company NYSE: SHW develops, manufactures, distributes and sells paints, coatings and related products. Its offerings include architectural paints, industrial coatings, wood finishes, protective coatings, automotive refinishing products, floor coatings and related supplies marketed under brands such as Sherwin-Williams, Valspar, Minwax, Krylon and Dutch Boy.

Founded in 1866 and headquartered in Cleveland, Ohio, Sherwin-Williams serves professional contractors, do-it-yourself consumers, industrial manufacturers, commercial businesses and other customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.